Cargando…
Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren’s disease, with an embedded dose response study.
Dupuytren’s disease is a common fibrotic condition of the hand affecting 4% of the population and causes the fingers to curl irreversibly into the palm. It has a strong familial tendency, there is no approved treatment for early stage disease, and patients with established digital contractures are m...
Autores principales: | Nanchahal, Jagdeep, Ball, Catherine, Swettenham, Jennifer, Dutton, Susan, Barber, Vicki, Black, Joanna, Copsey, Bethan, Dritsaki, Melina, Taylor, Peter, Gray, Alastair, Feldmann, Marc, Lamb, Sarah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701439/ https://www.ncbi.nlm.nih.gov/pubmed/29218326 http://dx.doi.org/10.12688/wellcomeopenres.11466.2 |
Ejemplares similares
-
Economic evaluation plan of a randomised controlled trial of intra-nodular injection of anti-TNF and placebo among patients with early Dupuytren’s disease: Repurposing Anti-TNF for Treating Dupuytren’s Disease (RIDD)
por: Png, May Ee, et al.
Publicado: (2019) -
Anti-tumour necrosis factor therapy for early-stage Dupuytren’s disease (RIDD): a phase 2b, randomised, double-blind, placebo-controlled trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2022) -
What do we know about managing Dupuytren’s disease cost-effectively?
por: Dritsaki, Melina, et al.
Publicado: (2018) -
Cost-effectiveness of adalimumab for early-stage Dupuytren’s disease: an economic evaluation based on a randomized controlled trial and individual-patient simulation model
por: Dakin, Helen, et al.
Publicado: (2022) -
Anti-Tumour Necrosis Factor Therapy for Dupuytren's Disease: A Randomised Dose Response Proof of Concept Phase 2a Clinical Trial
por: Nanchahal, Jagdeep, et al.
Publicado: (2018)